United States Eculizumab Market Report 2017

January 2018 | 101 pages | ID: U48A416F57AEN
QYResearch

Abstracts

In this report, the United States Eculizumab market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Eculizumab in these regions, from 2012 to 2022 (forecast).

United States Eculizumab market competition by top manufacturers/players, with Eculizumab sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Alexion

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Plasma Exchange
• Plasma Infusion

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• PNH
• aHUS
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Eculizumab Market Report 2017

1 ECULIZUMAB OVERVIEW

1.1 Product Overview and Scope of Eculizumab
1.2 Classification of Eculizumab by Product Category
  1.2.1 United States Eculizumab Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Eculizumab Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Plasma Exchange
  1.2.4 Plasma Infusion
1.3 United States Eculizumab Market by Application/End Users
  1.3.1 United States Eculizumab Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 PNH
  1.3.3 aHUS
  1.3.4 Other
1.4 United States Eculizumab Market by Region
  1.4.1 United States Eculizumab Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Eculizumab Status and Prospect (2012-2022)
  1.4.3 Southwest Eculizumab Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Eculizumab Status and Prospect (2012-2022)
  1.4.5 New England Eculizumab Status and Prospect (2012-2022)
  1.4.6 The South Eculizumab Status and Prospect (2012-2022)
  1.4.7 The Midwest Eculizumab Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Eculizumab (2012-2022)
  1.5.1 United States Eculizumab Sales and Growth Rate (2012-2022)
  1.5.2 United States Eculizumab Revenue and Growth Rate (2012-2022)

2 UNITED STATES ECULIZUMAB MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Eculizumab Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Eculizumab Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Eculizumab Average Price by Players/Suppliers (2012-2017)
2.4 United States Eculizumab Market Competitive Situation and Trends
  2.4.1 United States Eculizumab Market Concentration Rate
  2.4.2 United States Eculizumab Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Eculizumab Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ECULIZUMAB SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Eculizumab Sales and Market Share by Region (2012-2017)
3.2 United States Eculizumab Revenue and Market Share by Region (2012-2017)
3.3 United States Eculizumab Price by Region (2012-2017)

4 UNITED STATES ECULIZUMAB SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Eculizumab Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Eculizumab Revenue and Market Share by Type (2012-2017)
4.3 United States Eculizumab Price by Type (2012-2017)
4.4 United States Eculizumab Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ECULIZUMAB SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Eculizumab Sales and Market Share by Application (2012-2017)
5.2 United States Eculizumab Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ECULIZUMAB PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Alexion
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Eculizumab Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Alexion Eculizumab Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview

7 ECULIZUMAB MANUFACTURING COST ANALYSIS

7.1 Eculizumab Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Eculizumab

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Eculizumab Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Eculizumab Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ECULIZUMAB MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Eculizumab Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Eculizumab Sales Volume Forecast by Type (2017-2022)
11.3 United States Eculizumab Sales Volume Forecast by Application (2017-2022)
11.4 United States Eculizumab Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Eculizumab
Figure United States Eculizumab Market Size (K Vial) by Type (2012-2022)
Figure United States Eculizumab Sales Volume Market Share by Type (Product Category) in 2016
Figure Plasma Exchange Product Picture
Figure Plasma Infusion Product Picture
Figure United States Eculizumab Market Size (K Vial) by Application (2012-2022)
Figure United States Sales Market Share of Eculizumab by Application in 2016
Figure PNH Examples
Table Key Downstream Customer in PNH
Figure aHUS Examples
Table Key Downstream Customer in aHUS
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Eculizumab Market Size (Million USD) by Region (2012-2022)
Figure The West Eculizumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Eculizumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Eculizumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Eculizumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Eculizumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Eculizumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Eculizumab Sales (K Vial) and Growth Rate (2012-2022)
Figure United States Eculizumab Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Eculizumab Market Major Players Product Sales Volume (K Vial) (2012-2017)
Table United States Eculizumab Sales (K Vial) of Key Players/Suppliers (2012-2017)
Table United States Eculizumab Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Eculizumab Sales Share by Players/Suppliers
Figure 2017 United States Eculizumab Sales Share by Players/Suppliers
Figure United States Eculizumab Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Eculizumab Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Eculizumab Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Eculizumab Revenue Share by Players/Suppliers
Figure 2017 United States Eculizumab Revenue Share by Players/Suppliers
Table United States Market Eculizumab Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Eculizumab Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Eculizumab Market Share of Top 3 Players/Suppliers
Figure United States Eculizumab Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Eculizumab Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Eculizumab Product Category
Table United States Eculizumab Sales (K Vial) by Region (2012-2017)
Table United States Eculizumab Sales Share by Region (2012-2017)
Figure United States Eculizumab Sales Share by Region (2012-2017)
Figure United States Eculizumab Sales Market Share by Region in 2016
Table United States Eculizumab Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Eculizumab Revenue Share by Region (2012-2017)
Figure United States Eculizumab Revenue Market Share by Region (2012-2017)
Figure United States Eculizumab Revenue Market Share by Region in 2016
Table United States Eculizumab Price (USD/Unit) by Region (2012-2017)
Table United States Eculizumab Sales (K Vial) by Type (2012-2017)
Table United States Eculizumab Sales Share by Type (2012-2017)
Figure United States Eculizumab Sales Share by Type (2012-2017)
Figure United States Eculizumab Sales Market Share by Type in 2016
Table United States Eculizumab Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Eculizumab Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Eculizumab by Type (2012-2017)
Figure Revenue Market Share of Eculizumab by Type in 2016
Table United States Eculizumab Price (USD/Unit) by Types (2012-2017)
Figure United States Eculizumab Sales Growth Rate by Type (2012-2017)
Table United States Eculizumab Sales (K Vial) by Application (2012-2017)
Table United States Eculizumab Sales Market Share by Application (2012-2017)
Figure United States Eculizumab Sales Market Share by Application (2012-2017)
Figure United States Eculizumab Sales Market Share by Application in 2016
Table United States Eculizumab Sales Growth Rate by Application (2012-2017)
Figure United States Eculizumab Sales Growth Rate by Application (2012-2017)
Table Alexion Basic Information List
Table Alexion Eculizumab Sales (K Vial), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alexion Eculizumab Sales Growth Rate (2012-2017)
Figure Alexion Eculizumab Sales Market Share in United States (2012-2017)
Figure Alexion Eculizumab Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Eculizumab
Figure Manufacturing Process Analysis of Eculizumab
Figure Eculizumab Industrial Chain Analysis
Table Raw Materials Sources of Eculizumab Major Players/Suppliers in 2016
Table Major Buyers of Eculizumab
Table Distributors/Traders List
Figure United States Eculizumab Sales Volume (K Vial) and Growth Rate Forecast (2017-2022)
Figure United States Eculizumab Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Eculizumab Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Eculizumab Sales Volume (K Vial) Forecast by Type (2017-2022)
Figure United States Eculizumab Sales Volume (K Vial) Forecast by Type (2017-2022)
Figure United States Eculizumab Sales Volume (K Vial) Forecast by Type in 2022
Table United States Eculizumab Sales Volume (K Vial) Forecast by Application (2017-2022)
Figure United States Eculizumab Sales Volume (K Vial) Forecast by Application (2017-2022)
Figure United States Eculizumab Sales Volume (K Vial) Forecast by Application in 2022
Table United States Eculizumab Sales Volume (K Vial) Forecast by Region (2017-2022)
Table United States Eculizumab Sales Volume Share Forecast by Region (2017-2022)
Figure United States Eculizumab Sales Volume Share Forecast by Region (2017-2022)
Figure United States Eculizumab Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources